AA
Amino acids
cAMP
Cyclic adenosine monophosphatase
AR
Adrenergic receptor
AZA
Azathioprin (drug)
BBB
Blood-Brain-Barrier
CD4+
Autoimmune (aggressive) T-Lymphocyte, type CD4+
CD8+
Autoimmune (aggressive) T-Lymphocyte,
type CD8+
CMP
Cow Milk Protein
COP
Copolymer-1 (Copraxone,
Glatimer-acetate = drug)
CSF
Cerebrospinal
fluid
CT
Computed tomography
EAE
Experimental
autoimmune encephalomyelitis
EAN
Autoimmune
experimental neuritis
EBM
Evidence-Based
Medicine
EBV
Epstein-Barr virus
EDSS
Expanded
Disability Severity Scale
EPA
Eicosapentaen
Acid (in fish oil)
FDA
Food
and Drug Agency (USA)
FTY
Fingolimod (drug)
GBP
Gabapentin
(drug)
GSH
Glutathione
Hg
Mercury
(chem.)
HTLV-1
Human
T-cell lymphotropic virus type 1
IFN
Interferon
IFNB
Interferon-beta
(drug)
IL
Interleukin
(1-20)
IMPDH Inosine
monophosphate dehydrogenase
IVIG
Intravenous
immuneglobulin-G (drug)
LT
Leukotriene
MBP
Myelin
basic protein
MIT
Mitoxantrone
(drug)
MMF
Mycophenolate
mofetil (drug)
MMP
Matrix metalloproteinases
MOG
Myelin oligodendrocyte glycoprotein
MRI
Magnetic resonance imaging
MS
Multiple Sclerosis (but I guess you know now?)
MSRV
MS-Associated
Retrovirus
Nab
Neutralizing antibodies
NO
Nitric Oxide (chem.)
OLI
Oligodendrocytes
PAF
Platelet-activating factor
PAI
Plasminogen activator inhibitor
PBMNC Peripheral
blood mononuclear cells
PDE
Phosphodiesterase
PG
Prostaglandin
PP-MS Primary
progressive MS
RCT
Randomized controlled trial
RR-MS Relapsing-remittant
MS
S1P
Sphingosine-1-phosphate (receptor)
Se
Selenium (chem.)
SP-MS Secondary
progressive MS
TACE TNF-alpha
converting
enzyme
TGF
Transforming Growth Factor
TNF-a Tumor
necrosis factor alpha
t-PA
Tissue-type plasminogen activator
u-PA
Urokinase (drug)
Vit.
Vitamin